• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: REFLEXION MEDICAL, INC. REFLEXION X1; REFLEXION MEDICAL RADIOTHERAPY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

REFLEXION MEDICAL, INC. REFLEXION X1; REFLEXION MEDICAL RADIOTHERAPY SYSTEM Back to Search Results
Model Number RXM1000
Device Problem Application Program Problem: Dose Calculation Error (1189)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/17/2021
Event Type  malfunction  
Manufacturer Narrative
Reflexion has investigated the issue and determined the cause to be a code implementation defect in the treatment planning software.When reflexion's treatment planning system calculates dose, an accurate orientation for image, dose, primary beam, and scatter orientation (dose angles) is necessary.The scatter orientation in the dose calculation algorithm is incorrect for any patient orientation other than head first supine (hfs).The other patient orientations are head first prone (hfp), feet first prone (ffp), and feet first supine (ffs).Treatment plans for hfs are not affected.
 
Event Description
Patient (b)(6) received 15 out of 25 planned fractions for prostate bed + lymph node on the reflexion x1 system.During the initial 15 fractions on x1, the patient received an overdose of 9.6% to the planning target volume (ptv) due to a defect in the treatment planning software dose calculation.After the issue was identified, he received the rest of his treatment on another radiotherapy device, with the treating radiation oncologist deciding to drop some of the remaining fractions to compensate.The actual final delivered prescription dose amounted to a 1.25% underdose, which still meets clinical treatment goals.The final, aggregate delivered dose to all organs at risk still fell within acceptable tolerance dose limits.There is no expectation that the final dose distribution would cause excess risk of harm beyond the baseline level of risk of prostate bed radiotherapy.Additionally, the increase in the risk of secondary malignancy is minimal in this scenario.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFLEXION X1
Type of Device
REFLEXION MEDICAL RADIOTHERAPY SYSTEM
Manufacturer (Section D)
REFLEXION MEDICAL, INC.
25881 industrial blvd
hayward CA 94545
Manufacturer (Section G)
REFLEXION MEDICAL INC.
25881 industrial blvd
hayward CA 94545
Manufacturer Contact
aarti shukla
25881 industrial blvd
hayward, CA 94545
2138415999
MDR Report Key13011492
MDR Text Key288052227
Report Number3011716550-2021-00002
Device Sequence Number1
Product Code MUJ
UDI-Device Identifier00860003983805
UDI-Public(01)00860003983805(11)210524
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190978
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Remedial Action Notification
Type of Report Initial
Report Date 11/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberRXM1000
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/17/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/24/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction Number3011716550-12/9/21-001-C
Patient Sequence Number1
Patient SexPrefer Not To Disclose
-
-